Delta Lloyd’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$27.6M Buy
699,129
+24,435
+4% +$892K 0.77% 31
2017
Q1
$21.2M Buy
674,694
+1,776
+0.3% +$55.6K 0.64% 34
2016
Q4
$21M Buy
672,918
+60,087
+10% +$1.95M 0.66% 36
2016
Q3
$24.6M Sell
612,831
-30,129
-5% -$1.13M 0.76% 31
2016
Q2
$21.4M Sell
642,960
-72,933
-10% -$2.5M 0.72% 33
2016
Q1
$21.1M Buy
715,893
+670,653
+1,482% +$18.5M 0.7% 36
2015
Q4
$1.19M Sell
45,240
-661,242
-94% -$17.2M 0.04% 309
2015
Q3
$16.7M Buy
706,482
+3,678
+0.5% +$88.8K 0.53% 51
2015
Q2
$16.7M Buy
702,804
+84,540
+14% +$1.91M 0.52% 51
2015
Q1
$14.7M Sell
618,264
-2,838
-0.5% -$63.7K 0.46% 44
2014
Q4
$13.2M Sell
621,102
-14,388
-2% -$289K 0.39% 50
2014
Q3
$43.3M Buy
635,490
+115,470
+22% +$1.82M 0.39% 46
2014
Q2
$7.44M Buy
520,020
+2,070
+0.4% +$28.1K 0.23% 73
2014
Q1
$6.4M Buy
517,950
+11,886
+2% +$137K 0.22% 78
2013
Q4
$5.55M Sell
506,064
-550,782
-52% -$6.21M 0.19% 79
2013
Q3
$12.3M Sell
1,056,846
-138,600
-12% -$1.62M 0.47% 46
2013
Q2
$13.4M Buy
+1,195,446
New +$14.2M 0.52% 39

Other funds holding EW

Delta Lloyd's EW Position: Q2 2017 in Review

Delta Lloyd increased its Edwards Lifesciences (EW) stake by 3.6% in Q2 2017, buying an estimated $892K and bringing the position to 699,129 shares worth $27.6M. The position accounts for 0.77% of the portfolio, ranked #31.

Delta Lloyd first reported a position in EW in Q2 2013 and has held it in 17 quarters since. The position peaked at $43.3M in Q3 2014. 720 funds tracked by Wall St. Rank hold EW as of Q2 2017.

  • Delta Lloyd held 699,129 shares of Edwards Lifesciences worth $27.6M as of Q2 2017.
  • Delta Lloyd bought 24,435 Edwards Lifesciences shares in Q2 2017, an estimated $892K.
  • Edwards Lifesciences made up 0.77% of Delta Lloyd's portfolio in Q2 2017, its #31 holding.
  • Delta Lloyd first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 17 quarters since.
  • Delta Lloyd's Edwards Lifesciences position peaked at $43.3M in Q3 2014.
  • 720 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.